載入...
Rituximab: How approval history is reflected by a corresponding patent filing strategy
Because drug development is not a static process, a drug’s market authorisation may change over time. In many cases, the number of indications for which a drug is approved increases. Because this facet of drug development also comes at significant costs, a corresponding patent filing strategy is req...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Landes Bioscience
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4171018/ https://ncbi.nlm.nih.gov/pubmed/24866199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.29105 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|